Roche at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

Roche brings 2 presentations to PepTalk 2027 in Carlsbad. Its sessions span viral vector production and the design of tumor-targeted immune agonists. Specific work evolves the AAV Rep protein to improve recombinant vector production and shows how epitope choice shapes the synapse fit and in vivo efficacy of CEA-4-1BBL fusion proteins.

Organization	PepTalk 2027 Attendance
Roche Basel, Switzerland
roche.com Large pharma Swiss pharmaceutical and diagnostics company whose research centers discover antibodies, bispecifics and other protein therapeutics.	Talk Thu Jan 21 9:10am–9:40am Improved Recombinant Adeno-Associated Viral Vector Production via Molecular Evolution of the Viral Rep Protein Recombinant Protein Production - Part 2 Talk Thu Jan 21 1:40pm–2:10pm Epitope Co-Selection Governs Synaptic Compatibility and in vivo Efficacy of Tumor-Targeted CEA-4-1BBL Fusion Proteins Emerging T Cell Engagers

Instantly find 20 buyers from Roche

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction